These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2485902)

  • 1. Contribution of clinical pharmacology to a rational use of cardiac glycosides in Czechoslovakia.
    Sechser T; Petrásek R; Stika L; Modr Z; Elis J; Malý J
    Pol J Pharmacol Pharm; 1989; 41(6):527-32. PubMed ID: 2485902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utilization of cardiac glycosides in Czechoslovakia--does it correspond to need?].
    Sechser T; Stika L; Modr Z; Elis J; Malý J
    Cas Lek Cesk; 1989 May; 128(20):609-16. PubMed ID: 2752396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication)].
    Jordan D; Junge N; Schröder K; Schulz K; Spangenberg K; Wüstenberg PW
    Z Arztl Fortbild (Jena); 1975 Oct; 69(19):1017-21. PubMed ID: 1210392
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardenolide glycosides. XVI. Studies on the stability of lanatoside C and of the complex of lanatosides ABC in drug forms].
    Michalska B; Zurkowska J; Ozarowski A
    Acta Pol Pharm; 1966; 23(4):325-9. PubMed ID: 5959373
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selection of cardiac glycosides for acute usage].
    Beermann B; Lundman T
    Lakartidningen; 1974 Mar; 71(10):919. PubMed ID: 4826126
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of cardiac glycosides].
    Haustein KO
    Pol Tyg Lek; 1978 May; 33(20):817-20. PubMed ID: 673918
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of the cardiac glycosides lanatoside C and strophanthin K on left on left ventricular function in patients with mitral stenosis].
    Dubiel JP; Kolasińska-Kloch W
    Folia Med Cracov; 1982-1983; 24(1-2):25-39. PubMed ID: 7187367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Digitalis therapy in clinical practice].
    Weinbergová O; Dobes P; Vaverková H; Ficker L; Kvapil L; Veselý J; Hrubanová Z; Kubík Z; Hrabal A; Podstatová H
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():203-12. PubMed ID: 2530817
    [No Abstract]   [Full Text] [Related]  

  • 9. [Practical use of cardiac glycosides].
    Ignat'ev MV
    Voen Med Zh; 1976 Sep; (9):78-80. PubMed ID: 1034366
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cumulative effects of lanata glycosides].
    Feldenkirchen A
    Med Welt; 1966 Sep; (36):1906-9. PubMed ID: 5922122
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of proscillaridin A in the therapy of cardiac insufficiency in the aged].
    Castrucci D; Morini PL
    Minerva Med; 1967 Nov; 58(91):3917-21. PubMed ID: 6081708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
    Hansel J
    Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular drugs in Czechoslovakia--registration and consumption data.
    Seflová M; Sechser T; Strnadová J; Skop B; Váchová M; Svihovec J
    Pol J Pharmacol Pharm; 1989; 41(6):533-7. PubMed ID: 2485903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of cardiac glycoside therapy].
    Rösner K
    Z Gesamte Inn Med; 1979 Jun; 34(12):337-8. PubMed ID: 506349
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiac glycosides: indications, selection and dosage].
    Kuhlmann J
    Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative studies on the therapeutic range of cardiac glycosides].
    Diederen W; Kadatz R
    Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the preoperative and postoperative cardiac glycoside therapy].
    Endte K; Köle W; Müller V; Werner H
    Wien Med Wochenschr; 1968 Mar; 118(13):276-80. PubMed ID: 5672069
    [No Abstract]   [Full Text] [Related]  

  • 19. The usefulness of intravenous lanatoside C in paroxysmal ventricular tachycardia not due to myocardial infarction.
    SHAPIRO E; WEINER H; BERNSTEIN JL
    Perm Found Med Bull; 1952 Aug; 10(1-4):27-38. PubMed ID: 14948359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles and directives for practical treatment with cardiac glycosides].
    Dörffel EF
    Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.